Edition:
United States

Benitec Biopharma Ltd (BNTC.OQ)

BNTC.OQ on NASDAQ Stock Exchange Capital Market

2.90USD
3:59pm EST
Change (% chg)

$-0.03 (-1.02%)
Prev Close
$2.93
Open
$3.04
Day's High
$3.04
Day's Low
$2.88
Volume
3,925
Avg. Vol
10,595
52-wk High
$5.48
52-wk Low
$1.31

Latest Key Developments (Source: Significant Developments)

Benitec Biopharma Posts Qtrly ‍Loss Of A$2.9 mln
Tuesday, 28 Nov 2017 11:38pm EST 

Nov 29 (Reuters) - Benitec Biopharma Ltd ::QTRLY ‍LOSS OF A$2.9 MILLION VERSUS PROFIT OF A$0.8 MILLION​.  Full Article

Benitec biopharma signs new research and collaboration agreement
Wednesday, 21 Dec 2016 05:42pm EST 

Benitec Biopharma Ltd :New research and collaboration agreement has been signed with royal holloway university of london.  Full Article

Benitec Biopharma says Greg West appointed CEO
Wednesday, 10 Aug 2016 05:00am EDT 

Benitec Biopharma Ltd : Says Bryan Dulhunty appointed CFO .Cliff Holloway appointed CBO and COO.  Full Article

Benitec Biopharma appoints Greg West as chief executive officer
Tuesday, 9 Aug 2016 07:32pm EDT 

Benitec Biopharma Ltd : Restructuring of senior executive team . Says appointment of Greg West as chief executive officer .Bryan Dulhunty appointed as CFO.  Full Article

Benitec Biopharma receives cash refund under government's R&D tax incentive scheme
Thursday, 16 Jun 2016 12:36am EDT 

Benitec Biopharma Ltd : It has received a $3.6 million cash refund under the federal government's research and development tax incentive scheme .  Full Article

BRIEF-Benitec Biopharma Posts Qtrly ‍Loss Of A$2.9 mln

* QTRLY ‍LOSS OF A$2.9 MILLION VERSUS PROFIT OF A$0.8 MILLION​ Source text for Eikon: Further company coverage: